We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

DXST:NASDAQDecent Holding Inc. Analysis

Data as of 2026-06-13 - not real-time

$2.28

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Decent Holding Inc. (DXST) trades at a fraction of its book value (P/B ~0.19) and exhibits a very low price‑to‑sales multiple, suggesting a potentially deep discount. However, the company is posting negative earnings, a trailing EPS of –0.5, and operating cash flow losses exceeding $3 million, while its debt‑to‑equity ratio sits above 1.3, indicating a strained balance sheet. Technically, the current price of $2.28 sits below both the 20‑day (≈$2.55) and 50‑day (≈$2.43) moving averages, with a neutral RSI in the mid‑40s and a modestly bullish MACD histogram, while volume is trending upward. Volatility is extreme, exceeding 380% over the past 30 days, and the beta of ~0.85 points to market‑aligned price swings.
Recent news highlights a strategic move into an integrated AI‑driven platform for China’s aging population, which could diversify revenue streams beyond wastewater treatment. Yet, this initiative is nascent, with no disclosed financial impact, and the core business continues to shrink (revenue down 20%). The combination of deep valuation gaps, deteriorating fundamentals, and high price volatility creates a mixed outlook that leans toward caution.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 4/10

Key Factors

  • price hovering just above the identified support level
  • increasing trading volume indicating short‑term interest
  • neutral technical momentum with a modest bullish MACD

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • significant valuation discount relative to book and sales
  • potential upside from the new AI‑driven platform diversification
  • persistent negative cash flow and high debt burden

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • ongoing losses and negative profit margins
  • high leverage and deteriorating balance sheet health
  • extreme price volatility and limited liquidity

Key Metrics & Analysis

Financial Health

Revenue Growth-20.00%
Profit Margin-2.49%
ROE-5.06%
ROA-0.61%
Debt/Equity1.38
P/B Ratio0.2
Op. Cash Flow$-3455557
Free Cash Flow$-2991212
Industry P/E30.6

Technical Analysis

TrendNeutral
RSI46.3
Support$1.50
Resistance$7.68
MA 20$2.55
MA 50$2.43
MA 200$21.72
MACDBullish
VolumeIncreasing
Fear & Greed Index89.86

Valuation

GradeUndervalued
TypeBlend

Risk Assessment

Beta0.85
Volatility384.14%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.